Koyfin Home > Directory > Health Care > Acadia Pharmaceutica > Total Debt / EBITDA

Acadia Pharmaceutica Total Debt / EBITDA Chart (ACAD)

Acadia Pharmaceutica annual/quarterly Total Debt / EBITDA from 2010 to 2020.
  • Acadia Pharmaceutica Total Debt / EBITDA for the quarter ending June 06, 2020 was $0m a -18.81% increase of 0m year over year
  • Acadia Pharmaceutica Total Debt / EBITDA for the last 12 months ending June 06, 2020 was $0m a -12.38% increase of 0m year over year
  • Acadia Pharmaceutica Annual Total Debt / EBITDA for 2019 was $0m a 96.55% decrease of 0m from 2018
  • Acadia Pharmaceutica Annual Total Debt / EBITDA for 2011 was $0m a 450.53% decrease of 0m from 2010
  • Acadia Pharmaceutica Annual Total Debt / EBITDA for 2010 was $0m
Other Ratios Metrics:
  • Acadia Pharmaceutica Total Debt / Capital for the quarter ending September 09, 2012 was $0m a -708.88% decrease of 0m year over year
  • Acadia Pharmaceutica Other Liabilities for the quarter ending December 12, 2018 was $2m a 49.81% increase of 1m year over year
  • Acadia Pharmaceutica Total Debt / Equity for the quarter ending September 09, 2012 was $0m a -710.06% decrease of 0m year over year
View Chart On Koyfin

Quarterly ACAD Total Debt / EBITDA Data

06/2020$0m
03/2020$0m
12/2019$0m
09/2019$0m
06/2019$0m
03/2019$0m
09/2012$0m
06/2012$0m
03/2012$0m
12/2011$0m

Annual ACAD Total Debt / EBITDA Data

2019$0m
2011$0m
2010$0m